tbuckley/cabot-search huggingface dataset:
Major Segments of Trachea Resected
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medical Mobilization and the War
Journal: JAMA (1918)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Error in Affiliation and Address
Authors: Jie Wang, Shiang Leaw, Shun Lu
Journal: JAMA Oncology (2021)

The Poem titled, “For the Necessary: You,”1 published online December 23, 2020, and in the February 2021 print issue, included the incorrect institution name in the author affiliation and the Corresponding Author address. This article has been corrected online.
Cutaneous vasculitis
Authors: M. Hudson
Journal: British Journal of Dermatology (1996)

Journal Article Cutaneous vasculitis Get access M. Hudson M. Hudson Department of Genitourinary Medicine, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, U.K. Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 135, Issue 2, 1 August 1996, Page 331, https://doi.org/10.1111/j.1365-2133.1996.tb01177.x Published: 01 August 1996
Education Programs in Areas Allied to Medicine
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The exclusion or eradication of measles: cost-beneficial for whom?
Authors: Laurence S. Farer
Journal: JAMA (1985)

<h3>To the Editor.—</h3> I am writing to correct one misapprehension on the part of Dr Schoenbaum<sup>1</sup>in his thoughtful editorial, "On Herds, Border Guards, and Ambulatory Infection Control." While the "Ellis Island" approach to quarantine was abandoned many years ago, that is not to say there is no longer disease surveillance and control at our borders. For immigrants and refugees, scrutiny now begins at the point of origin rather than the point of arrival. Medical screening of immigrants and refugees is done before they are permitted to travel to the United States, thus eliminating the need to send people back from the port of entry. Moreover, since most persons arriving from abroad are not immigrants or refugees, the Public Health Service (PHS) has the authority to detain at the port of entry<i>any</i>person (eg, tourist, visitor, businessman, returning permanent resident, and returning US citizen) suspected of having certain
Art and Medicine
Journal: JAMA (2000)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
MEDICAL EVIL-DOERS BEFORE THE ENGLISH LAW.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Progress Toward Elimination of Haemophilus influenzae type b Disease Among Infants and Children—United States, 1987-1993
Journal: JAMA (1994)

Before effective vaccines were available, Haemophilus influenzae type b (Hib) was the most common cause of bacterial meningitis among children in the United States, and an estimated one of 200 children aged < 5 years developed invasive Hib disease. From December 1987--when Hib conjugate vaccines were introduced--through 1994, the incidence of invasive Hib disease declined 95% among children aged < 5 years. Eliminating invasive Hib disease among children aged < 5 years by 1996 is a goal of the Childhood Immunization Initiative (CII). This report summarizes data about trends in invasive H. influenzae (Hi) disease during 1987-1995 from three separate surveillance systems (CDC's National Notifiable Diseases Surveillance System [NNDSS]; the National Bacterial Meningitis and Bacteremia Reporting System [NBMBRS]; and an active, multistate, laboratory-based surveillance system). The findings underscore the need for age-appropriate vaccination of infants and for complete investigation and reporting of cases of invasive Hi disease.
Hand-Book of Emergencies and Common Ailments.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Erratum
Journal: BMJ (1910)

NOVA ET VETERA. [FEB.12, 19!Os describes generation and formation of the body, are almost conclusive proof that the poet had more than a superficial acquaintance with medicine.Vernon quotes from Varchi (Lez.8UZ Dante, 1841, Lez. 1) the following strong statement on this point:This canto is sufficient to prove Dante to have been a physi- -cian, philosopher, and theologian of the highest order.It -certainly proves him to have been a close student of Aristotle's De Generatione Animaliurn (for his embryology) and of Thomas Aquinas's Sumnma Theoloyiae (for his views on the origin of the soul), as must be evident to any one will trouble to look at the
Oleander interference in the digoxin radioimmunoassay in a fatal ingestion
Authors: J. Osterloh
Journal: JAMA (1982)

An elderly woman allegedly ingested oleander leaves and died. Ventricular arrhythmias and asystole were unresponsive to cardiopulmonary resuscitation, pharmacologic agents, and cardioversion. The patient, who had no access to digoxin, had an initial serum digoxin concentration of 5.8 ng/mL. Cross-reactivities between oleander extract and pure oleandrin and digoxin in the digoxin radioimmunoassay were 100:1 and 29,000:1, respectively. We postulate that glycosides in oleander leaves produced the elevated serum digoxin concentration. Based on an assumed volume of distribution of the oleander glycosides of 1 L/kg, the calculated lethal dose absorbed by our patient was 200 times greater than lethal doses in several animal species and corresponded to the absorption of 4 g of oleander leaves. (<i>JAMA</i>1982;247:1596-1597)
Premarket approval of medical devices
Journal: JAMA (1979)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mitochondrial COII Sequences and Modern Human Origins
Journal: Molecular Biology and Evolution (1994)

the last two of the three sentences in the second full paragraph on page 113 1 should read as follows:Templeton ( 1993 ) does not reject a 1-Myr-old human mitochondrial ancestor, based on estimates using a mutation rate for the hypervariable control subregions of 5.75-8.65 X IO-' /site/year/lineage (from Vigilant et al. 199 1).However, this range may be an underestimate: as we have observed, the hypervariable control subregions evolve roughly 10 times faster than more slowly evolving mtDNA regions, and from our data on the latter, the mutation rate may be as high as 13 X 10 -8 / site/year/lineage for hypervariable control subregions.
Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate
Authors: C. L. Strand
Journal: JAMA (1993)

<h3>Objective.</h3> —To determine if iodine tincture is a more effective skin antiseptic for blood culture collection than povidone-iodine, an iodophor. <h3>Design.</h3> —Pairwise comparisons across phases. In phases 1 and 3, blood culture skin preparation was performed with the iodophor; in phases 2 and 4, skin preparation was performed with iodine tincture. <h3>Setting.</h3> —Emergency department of a large urban teaching hospital. <h3>Patients.</h3> —All adult patients seen in the emergency department who had blood cultures collected because a systemic bacterial infection was suspected. <h3>Main Outcome Measure.</h3> —The blood culture contamination rate for the iodophor and iodine tincture skin preparations. <h3>Results.</h3> —A total of 8467 blood cultures were collected during the study, and 421 (4.97%) were classified as contaminated. The contamination rate for the blood cultures collected using the iodophor was 6.25%, and the contamination rate for the cultures using iodine tincture was 3.74%; this difference is statistically significant (<i>P</i>&lt;.00001). <h3>Conclusions.</h3> —The effectiveness of the skin antiseptic may be an important factor in determining contamination rate in blood culturing. If these results are confirmed by others, then institutions that have a high blood culture contamination rate when using an iodophor for skin preparation should consider changing to iodine tincture. (<i>JAMA</i>. 1993;269:1004-1006)
A novel chimeric fibroblast growth factor for liver parenchymal cells
Authors: T Imamura, T Tanahashi
Journal: Hepatology (1996)

Although fibroblast growth factor 1 (FGF-1) (formerly known as acidic FGF) but not FGF-2 (or basic FGF), has been suggested to play a pathophysiological role in liver regeneration, its clinical application has been restricted by its limited mitogenecity and heparin dependence. We report here that a chimeric human FGF protein, FGF-C(1211), is a heparin-independent potent mitogen for liver parenchymal cells both in vitro and in vivo . In the presence of serum and physiological concentration of insulin, FGF-C(1211) by itself induces as much as 55% of hepatocytes in culture to proliferate and up to 88% when used in combination with hepatocyte growth factor or epidermal growth factor. Furthermore, hepatocytes nuclear labeling in vivo with bromodeoxyuridine was markedly enhanced when FGF-C(1211) was injected intravenously into carbon tetrachloride-administered mice. Because FGF-C(1211) is heparin independent and nonantigenic, it has potential for clinical and preclinical applications.
Structure-Activity Relationships for Ulcerogenic and Adrenocorticolytic Effects of Alkyl Nitriles, Amines, and Thiols
Authors: Sandor Szabo, Edward S. Reynolds
Journal: Environmental Health Perspectives (1975)

In rats, a single administration of acrylonitrile (vinyl cyanide) produces a rapidly occurring bilateral adrenal apoplexy. Structure-activity studies have shown that a close derivative, propionitrile (ethyl cyanide), causes duodenal ulcer without markedly affecting the adrenal glands. Prolonging the two-carbon chain of propionitrile by a methyl group (n-butyronitrile) enhances, replacing the methyl by bromide or nitrile decreases, while substitution by an amino group abolistes the ulcerogenic potency and variably affects the adrenocorticolytic action. On assaying a large number of nonnitrile compounds as well for ulcerogenic effect, such as thiols and amines, this effect was found to be related to a two-carbon structure bearing electronegative radicals on one or both ends of the chain.
ASXL1 Mutations in AML: Molecular Biomarker for Secondary AML?
Authors: Jingmei Hsu, Anita J. Kumar, Martin P. Carroll, Noelle V. Frey, Nirav N. Shah, Zhao Jianhua, Elizabeth O. Hexner, Alison W. Loren, James K. Mangan, Alexander E. Perl, David Porter, Jennifer Morrissette, Selina M. Luger
Journal: Blood (2014)
In Reply:
Authors: Paul R. Helft
Journal: Journal of Clinical Oncology (2005)

have to be the control arm compared to another therapy.The other therapy could not be fludarabine, and autologous transplantation is not applicable to many patients, especially if a harvest is not possible for the patient who has never been in remission.Corticosteroids or cyclophosphamide, doxorubicin, vincristine, and prednisone based therapies are not likely to lead to MRD negative responses.Dr Goodman is right when he says that the article is a first step, and that much work needs to be done.I also agree that one should first do no harm.But in the high-risk B-CLL patient, doing nothing is the most harmful thing.
THE COMMON BACTERIAL INFECTIONS OF THE DIGESTIVE TRACT AND THE INTOXICATIONS ARISING THEREFROM.
Authors: CHRISTIAN A. HERTER
Journal: JAMA (1907)

After presenting some general considerations relative to the bacterial flora of the human digestive tract in health, and showing that none of the experimental studies made by investigators is really conclusive as to the necessity of bacterial action in the digestive tract for the maintenance of health in adult mammals of the highest type, Dr. Herter proceeded: Clearly, then, the intestinal bacteria are not required to carry on the ordinary digestive processes of normal nutrition. It has been supposed that the intestinal bacteria aid in the digestion of cellulose which they are undoubtedly able to decompose fermentatively. This argument loses much of its force if it be true, as lately maintained by Bergmann, that most of the cellulose eaten by herbivora is provided with intracellular enzymes capable of decomposing cellulose. The real significance of the normal intestinal flora probably lies, not in any immediate relation to processes of digestion but
Current Comment
Journal: JAMA (1931)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Russian and US researchers develop 'biochips' for faster, inexpensive biomedical tests
Authors: A. A. Skolnick
Journal: JAMA (1996)

RUSSIAN AND US researchers at Argonne National Laboratory, Argonne, Ill, are working together to develop tiny "biochips" that may revolutionize the way laboratories decode DNA sequences and perform pathologic studies and clinical tests. According to the researchers, thousands of biochemical sensors for various DNA sequences, antibodies, peptides, or other biomedically significant markers can be packed onto a single biochip the size of an electronic microchip and read automatically by computer. The project is headed by Andrei D. Mirzabekov, PhD, director of Argonne's Human Genome Project in the Center for Mechanistic Biology and also director of the Russian Academy of Sciences' W. A. Englehardt Institute of Molecular Biology in Moscow. Mirzabekov, who is dividing his time equally between the two centers, says the biochip was developed to greatly speed up the international effort to sequence the entire human genome. However, its applications are more far-reaching. For example, the technology can be
Physicians need better line on how, when to respond to patients via telephone
Authors: J. W. Zylke
Journal: JAMA (1990)

FOR MANY patients, reaching out and touching their physicians by telephone is a convenience. For many physicians, telephone calls are at best a bother and at worst a liability. But they are also a fact of life for many clinicians. It has been estimated that pediatricians, for example, spend 27% of practice time on the phone. Some expertise in handling phone calls would therefore be useful, and it may become necessary as concern has been raised about potential medicolegal liability arising from advice given over the telephone. Dealing with patients by telephone clearly is not the same as seeing them. Obviously, a physician cannot perform a physical examination or do laboratory tests. Peter Curtis, MD, professor of family medicine at the University of North Carolina, Chapel Hill, points out a number of other differences. For example, "there's a smaller number of problems that present than the general scattering of primary
A diagnostic approach of non-alcoholic fatty liver disease with a machine learning model using parameters derived from ultrasound B-mode examination
Authors: Petros Drazinos, Ilias Gatos, Ioannis Theotokas, Spyros Yarmenitis, Emmanouel Koullias, Ioannis-Georgios Koskinas, Pavlos Zoumpoulis
Journal: Journal of Hepatology (2020)